Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah

from Rx for Biotech · host Podcast Host Chris Leidli

Our guest in this episode is Cove Therapeutics CEO, Niren Shah, who discusses the pitfalls of current viral vector based gene therapies and shares how Cove's next generation non-viral gene delivery platform overcomes many of the challenges of viral vectors.

Episode metadata supplied by the publisher feed · Published Nov 7, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Next Generation Non-Viral Gene Therapies with Cove Therapeutics CEO, Niren Shah

0:00 24:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rx for Biotech?

This episode is 24 minutes long.

When was this Rx for Biotech episode published?

This episode was published on November 7, 2022.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!